Developing a free, effective Covid-19 vaccine for all
It will require not just collective effort, but also clear alignment between global and national public interests to do this successfully.
IN THE early weeks of 2020, it started to dawn on people that Covid-19 could be the long-dreaded but expected "Disease X" - a global pandemic caused by an unknown virus. Three months later, the majority of the world's population is in lockdown, and it is clear that we are only as healthy as our neighbours - locally, nationally, and internationally.
Strong health systems, adequate testing capacity, and an effective, universally available vaccine will be key to protecting societies from Covid-19. But ensuring that no one is left behind requires not just unprecedented collective investment, but also a very different approach.
Researchers at universities and companies around the world are racing to develop a vaccine. And current progress is encouraging: 73 vaccine candidates are actively being explored or are in pre-clinical development, while five already have entered clinical trials.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Columns
‘Competition for talent’ a poor excuse to keep key executives’ pay under wraps
OCBC should put its properties into a Reit and distribute the trust’s units to shareholders
Why a stronger US dollar is dangerous
An overstimulated US economy is asking for trouble
Too many property agents? Cap commissions on home sales
Time to study broadening of private market access